This cholesterol drug promised to be a game-changer. Why did it flop in the clinic — and is there still hope?
In early September, pharmaceutical giant Novartis issued a press release that sent shock waves through the cardiology community.…
Multiview deep learning improves detection of major cardiac conditions from echocardiography
Cohort selection and data sources Our UCSF echocardiogram dataset comprised studies acquired on adult patients at UCSF between…
Is HRT in menopause healthy? US label change triggers debate
A ‘black box’ warning has appeared on hormone replacement therapies in the United States for more than 20…